- Inspection year
- 2025
- Report date
- 20-Nov-2025
- PCAOB release
- 104-2026-012
- Audits reviewed
- 3
- Audits w/ Part I.A deficiencies
- 2
- Part I.A deficiency rate
- 67%
- Part I.A deficiencies
- 12
- Part I.B deficiencies
- 12
- Report
- View PDF ↗
Deficiencies (12)
Grouped by issuer and in the same order as the PCAOB report, so each item ties back directly to the source.
Issuer A6 deficiencies
| # | Area | Deficiency | Standard | Flags |
|---|---|---|---|---|
| 1 | Revenue and Related Accounts | The firm's internal inspection program had inspected this audit and reviewed the Revenue and Related Accounts area and also identified certain of the deficiencies below. The firm did not perform any test of details to address the fraud risk related to the occurrence of certain revenue. (AS 2301.08 and .13) Financial statement audit only | AS 2301.8; AS 2301.13 | |
| 2 | Revenue and Related Accounts | The firm's internal inspection program had inspected this audit and reviewed the Revenue and Related Accounts area and also identified certain of the deficiencies below. The firm did not perform procedures to test or test controls over the accuracy and completeness of certain system-generated reports that it used to test certain other revenue. (AS 1105.10) Financial statement audit only | AS 1105.10 | |
| 3 | Revenue and Related Accounts | The firm's internal inspection program had inspected this audit and reviewed the Revenue and Related Accounts area and also identified certain of the deficiencies below. The firm did not perform any substantive procedures to test deferred revenue. (AS 2301.08) Financial statement audit only | AS 2301.8 | |
| 4 | Investments | The firm's approach for substantively testing the issuer's impairment analysis for certain investments was to develop an independent expectation. The following deficiency was identified. • The firm did not perform procedures to demonstrate that it had a reasonable basis for the method and assumptions it used including taking into account (1) the requirements of certain elements of the applicable financial reporting framework and (2) its understanding of the issuer's process including the issuer's use of a flat rate for impairment so that its independent expectation considered the factors relevant to the estimate. (AS 2501.21 and .22) Financial statement audit only | AS 2501.21; AS 2501.22 | Significant risk |
| 5 | Investments | The firm's approach for substantively testing the issuer's impairment analysis for certain investments was to develop an independent expectation. The following deficiency was identified. • The firm did not evaluate the significant difference between its independent expectation and the issuer's recorded impairment beyond concluding that the issuer's recorded impairment was more conservative. (AS 2501.26; AS 2810.13) Financial statement audit only | AS 2501.26; AS 2810.13 | Significant risk |
| 6 | Investments | The firm did not identify and evaluate a departure from GAAP related to the issuer's omission of a disclosure required by FASB ASC Topic 235 Notes to Financial Statements. (AS 2810.30 and .31) Unrelated to our review the issuer reevaluated its disclosures for investments and determined that a disclosure was omitted. The issuer subsequently corrected this omission in a restatement of its financial statements and the firm issued an audit report on the issuer's restated financial statements. Financial statement audit only | AS 2810.30; AS 2810.31 | Significant risk |
Issuer B6 deficiencies
| # | Area | Deficiency | Standard | Flags |
|---|---|---|---|---|
| 1 | Revenue | The firm's substantive procedures to test revenue included selecting a sample of revenue transactions for testing. The firm's sample was not representative of the population because the firm did not select any transactions for one type of revenue without performing procedures to determine whether all revenue transactions were homogeneous based on their characteristics. (AS 2315.16) Financial statement audit only | AS 2315.16 | |
| 2 | Revenue | The firm did not evaluate whether the issuer's disclosures were in compliance with the requirements of FASB Topic ASC 606 Revenue from Contracts with Customers to disaggregate revenue into categories that depict how the nature amount timing and uncertainty of revenue and cash flows are affected by economic factors. (AS 2301.08 and .13) Financial statement audit only | AS 2301.8; AS 2301.13 | |
| 3 | Investments | The issuer engaged a specialist to determine the fair value of an equity investment. The firm's approach for substantively testing the fair value of the investment was to test the issuer's process and the firm used an auditor-engaged specialist to evaluate certain significant assumptions the company's specialist used. The following deficiency was identified. • The firm did not evaluate the reasonableness of a certain significant assumption developed by the company's specialist. (AS 1105.A8b) Financial statement audit only | AS 1105.A8b | Significant risk |
| 4 | Investments | The issuer engaged a specialist to determine the fair value of an equity investment. The firm's approach for substantively testing the fair value of the investment was to test the issuer's process and the firm used an auditor-engaged specialist to evaluate certain significant assumptions the company's specialist used. The following deficiency was identified. • The firm did not evaluate whether this was an investment in a variable interest entity that should have been consolidated by the issuer in accordance with FASB ASC Topic 810 Consolidation. (AS 2301.08 and .11) Financial statement audit only | AS 2301.8; AS 2301.11 | Significant risk |
| 5 | Investments | The issuer engaged a specialist to determine the fair value of an equity investment. The firm's approach for substantively testing the fair value of the investment was to test the issuer's process and the firm used an auditor-engaged specialist to evaluate certain significant assumptions the company's specialist used. The following deficiency was identified. • The firm did not evaluate whether a certain related asset was properly classified as a current asset in accordance with FASB ASC Topic 210 Balance Sheet. (AS 2301.08 and .11) Financial statement audit only | AS 2301.8; AS 2301.11 | Significant risk |
| 6 | Investments | The issuer engaged a specialist to determine the fair value of an equity investment. The firm's approach for substantively testing the fair value of the investment was to test the issuer's process and the firm used an auditor-engaged specialist to evaluate certain significant assumptions the company's specialist used. The following deficiency was identified. • The firm did not perform procedures to test the issuer's conclusion that no allowance was necessary for the related asset. (AS 2501.07) Financial statement audit only | AS 2501.7 | Significant risk |